Created in 2014 (United States), ALYFTEO own
18 sister brands
and 2214 competing brands.
ALYFTEO is owned by Vertex Pharma, listed on the stock exchange of New York
ALYFTEO is part of the Biotechnology activity sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.